One main goal of anti-cancer therapies is to kill tumor cells without affecting the surrounding normal cells. Therefore, many drugs are designed to target tumor-specific antigens, which are molecules ...
The "Human Leukocyte Antigen (HLA) Targeted Therapy, Clinical Trials, Therapeutic Approaches & Market Opportunity Insight 2026" report has been added to ResearchAndMarkets.com's offering. This report ...
AURORA, Colo., Oct. 28, 2025 /PRNewswire/ -- RheumaGen, Inc., a cell and gene therapy company engineering a new class of therapeutics to cure common autoimmune diseases, today announced groundbreaking ...
Human LAG-3 homodimer (with domains D1, D2, D3 and D4) binding to two separate HLA-II (MHC-II) molecules on the surface of an antigen-presenting cell (APC), imposing a distinct 38° offset angle. This ...
The advances in molecular biology and genomic sequencing have helped in significantly increasing the accuracy, speed, and efficiency of HLA typing. Most of the conventional methods of serological ...
Cancer immunotherapy has revolutionized treatment for patients, whereby the body's own immune system is harnessed to destroy cancer cells. Typically, several molecules restrain the ability of T cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results